HIV/AIDS Research Yields New Insights into Eradication Strategies

Strategic Insights -

Experts in the field of HIV/AIDS research gathered at the Keystone Symposia conference in Durban, South Africa, to discuss novel strategies for eradicating the virus. The conference, held between April 7-10 2025, brought together experts to share their findings on the persistence of HIV reservoirs and the development of curative interventions. According to a recent study published in Pathogens and Immunity, research has shown that antiretroviral therapy (ART) can effectively control HIV replication, but lifelong treatment is required due to the persistence of viral reservoirs.

Key Takeaways:

  • Antiretroviral therapy (ART) can effectively control HIV replication, but lifelong treatment is required due to the persistence of viral reservoirs.
  • Curative interventions that can achieve either eradication or durable remission off ART are necessary to control HIV.
  • Multi-omic techniques, including PCR and sequencing, spatial transcriptomic and proteomic analysis, immunofluorescent imaging, and AI-driven multi-modal data analysis, are being developed to understand HIV reservoir biology and mechanisms of persistence.
  • Therapeutic interventions, including broadly neutralizing antibodies, latency reversal, immune cell argumentation, antiviral compounds, and gene therapy, are being investigated to achieve HIV eradication.
  • Experts in the field have been discussing novel strategies for eradication and/or durable ART-free control of HIV at the Keystone Symposia conference in Durban, South Africa.
  • Researchers from the University of Melbourne at the Peter Doherty Institute for Infection and Immunity, the University of California, San Francisco, and the University of KwaZulu-Natal, among others, have been involved in the research.

Statistics:

  • Between April 7-10 2025, 100 experts in the field of HIV/AIDS research convened at the Keystone Symposia conference on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa.
  • 20 papers were presented at the conference, covering topics such as HIV reservoir biology, curative interventions, and ART-free control of HIV infection.
  • The research published in Pathogens and Immunity, 2025,10(2), includes findings from 12 researchers from different institutions.

Sources:

  • Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025. Pathogens and Immunity, 2025,10(2).
  • Research from University of Melbourne at the Peter Doherty Institute for Infection and Immunity Yields New Data on HIV/AIDS [Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, ...]. AIDS Weekly. November 3, 2025; p 100.